BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19876915)

  • 1. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.
    De Milito A; Canese R; Marino ML; Borghi M; Iero M; Villa A; Venturi G; Lozupone F; Iessi E; Logozzi M; Della Mina P; Santinami M; Rodolfo M; Podo F; Rivoltini L; Fais S
    Int J Cancer; 2010 Jul; 127(1):207-19. PubMed ID: 19876915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells.
    Marino ML; Fais S; Djavaheri-Mergny M; Villa A; Meschini S; Lozupone F; Venturi G; Della Mina P; Pattingre S; Rivoltini L; Codogno P; De Milito A
    Cell Death Dis; 2010 Oct; 1(10):e87. PubMed ID: 21368860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulating tumor acidification as a cancer treatment strategy.
    McCarty MF; Whitaker J
    Altern Med Rev; 2010 Sep; 15(3):264-72. PubMed ID: 21155627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.
    De Milito A; Iessi E; Logozzi M; Lozupone F; Spada M; Marino ML; Federici C; Perdicchio M; Matarrese P; Lugini L; Nilsson A; Fais S
    Cancer Res; 2007 Jun; 67(11):5408-17. PubMed ID: 17545622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma.
    Azzarito T; Venturi G; Cesolini A; Fais S
    Cancer Lett; 2015 Jan; 356(2 Pt B):697-703. PubMed ID: 25449440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
    Luciani F; Spada M; De Milito A; Molinari A; Rivoltini L; Montinaro A; Marra M; Lugini L; Logozzi M; Lozupone F; Federici C; Iessi E; Parmiani G; Arancia G; Belardelli F; Fais S
    J Natl Cancer Inst; 2004 Nov; 96(22):1702-13. PubMed ID: 15547183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V-ATPase as an effective therapeutic target for sarcomas.
    Perut F; Avnet S; Fotia C; Baglìo SR; Salerno M; Hosogi S; Kusuzaki K; Baldini N
    Exp Cell Res; 2014 Jan; 320(1):21-32. PubMed ID: 24416789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism.
    Fais S
    J Intern Med; 2010 May; 267(5):515-25. PubMed ID: 20433578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protodynamic intracellular acidification by cis-urocanic acid promotes apoptosis of melanoma cells in vitro and in vivo.
    Laihia JK; Kallio JP; Taimen P; Kujari H; Kähäri VM; Leino L
    J Invest Dermatol; 2010 Oct; 130(10):2431-9. PubMed ID: 20520626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evaluation of Potential Cytotoxic Effect of Different Proton Pump Inhibitors on Different Human Cancer Cell Lines.
    Qasem A; Kasabri V; AbuRish E; Bustanji Y; Al-Hiari Y; Al-Abbasi R; Abu-Irmaileh B; Alalawi S
    Anticancer Agents Med Chem; 2020; 20(2):245-253. PubMed ID: 31663482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer.
    Song T; Jeon HK; Hong JE; Choi JJ; Kim TJ; Choi CH; Bae DS; Kim BG; Lee JW
    Cancer Res Treat; 2017 Jul; 49(3):595-606. PubMed ID: 27669706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin.
    Federici C; Petrucci F; Caimi S; Cesolini A; Logozzi M; Borghi M; D'Ilio S; Lugini L; Violante N; Azzarito T; Majorani C; Brambilla D; Fais S
    PLoS One; 2014; 9(2):e88193. PubMed ID: 24516610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells.
    Chen M; Zou X; Luo H; Cao J; Zhang X; Zhang B; Liu W
    Cell Biol Int; 2009 Sep; 33(9):1008-19. PubMed ID: 19501661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism.
    Giammarioli AM; Maselli A; Casagrande A; Gambardella L; Gallina A; Spada M; Giovannetti A; Proietti E; Malorni W; Pierdominici M
    Cancer Res; 2008 Jul; 68(13):5291-300. PubMed ID: 18593930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic pH via NF-κB favours VEGF-C expression in human melanoma cells.
    Peppicelli S; Bianchini F; Contena C; Tombaccini D; Calorini L
    Clin Exp Metastasis; 2013 Dec; 30(8):957-67. PubMed ID: 23784694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer.
    Yeo M; Kim DK; Park HJ; Cho SW; Cheong JY; Lee KJ
    Cancer Sci; 2008 Jan; 99(1):185. PubMed ID: 18224727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myrtenal-induced V-ATPase inhibition - A toxicity mechanism behind tumor cell death and suppressed migration and invasion in melanoma.
    Martins BX; Arruda RF; Costa GA; Jerdy H; de Souza SB; Santos JM; de Freitas WR; Kanashiro MM; de Carvalho ECQ; Sant'Anna NF; Antunes F; Martinez-Zaguilan R; Souad S; Okorokova-Façanha AL; Façanha AR
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):1-12. PubMed ID: 30279148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of proton pump inhibitors as adjunct treatment for triple-negative breast cancers. An introductory study.
    Goh W; Sleptsova-Freidrich I; Petrovic N
    J Pharm Pharm Sci; 2014; 17(3):439-46. PubMed ID: 25224353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways.
    Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J
    Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.